Optimal Imaging Protocols for Lung Cancer Staging. CT, PET, MR Imaging, and the Role of Imaging

Radiologic Clinics of North America

Volumn 50, Issue 5, 2012, Pages 935-949

  Paul, Narinder S ^a   Ley, Sebastian ^a   Metser, Ur ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

Author keywords

Computed tomography; Hybrid positron emission tomography; Lung cancer staging; Magnetic resonance imaging; Staging algorithm

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ALGORITHM; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CLINICAL PROTOCOL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DISTANT METASTASIS; HUMAN; IMAGE ANALYSIS; IMAGE RECONSTRUCTION; INTERMETHOD COMPARISON; LUNG CANCER; LYMPH NODE METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROCESS OPTIMIZATION; PROGNOSIS; REVIEW; SENSITIVITY AND SPECIFICITY; SIGNAL NOISE RATIO;

ALGORITHMS; CONTRAST MEDIA; HUMANS; LUNG NEOPLASMS; MAGNETIC RESONANCE IMAGING; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOGRAPHY, THORACIC; RADIOPHARMACEUTICALS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84866178778     PISSN: 00338389     EISSN: 15578275     Source Type: Journal    
DOI: 10.1016/j.rcl.2012.06.007     Document Type: Review

References (81)

1. Doria-Rose V.P., Szabo E. Screening and prevention of lung cancer. Lung cancer: a multidisciplinary approach to diagnosis and management 2010, 53-72. Demos Medical Publishing, New York. K.H. Kernstine, K.L. Reckamp (Eds.).
2. Dalrymple N.C., Prasad S.R., El-Merhi F.M., et al. Price of isotropy in multidetector CT. Radiographics 2007, 27:49-62.
3. Brenner D.J., Hall E.J. Computed tomography-an increasing source of radiation exposure. N Engl J Med 2007, 357:2277-2284.
4. Singh S., Kalra M.K., Gilman M.D., et al. Adaptive statistical iterative reconstruction technique for radiation dose reduction in chest CT: a pilot study. Radiology 2011, 259:565-573.
5. Kinahan P.E., Hasegawa B.H., Beyer T. X-ray-based attenuation correction for positron emission tomography/computed tomography scanners. Semin Nucl Med 2003, 33:166-179.
6. Webb W.R., Jensen B.G., Sollitto R., et al. Bronchogenic carcinoma: staging with MR compared with staging with CT and surgery. Radiology 1985, 156:117-124.
7. Patz E.F., Erasmus J.J., McAdams H.P., et al. Lung cancer staging and management: comparison of contrast - enhanced and nonenhanced helical CT of the thorax. Radiology 1999, 212:56-60.
8. Swensen S.J., Viggiano R.W., Midthun D.E., et al. Lung nodule enhancement at CT: multicentre study. Radiology 2000, 214:73-80.
9. 18F-FDG PET. J Nucl Med Technol 2006, 34(1):29-33.
10. ACR practice guidelines: ACR Practice Guideline for Performing FDG-PET/CT in Oncology. Accessed April 19, 2012.
11. McCullough C., Bruesewitz M.R., Kofler J.M., et al. Tools: overview of available options. Radiographics 2006, 26:503-512.
12. Sieren J.C., Ohno Y., Koyama H., et al. Recent technological and application developments in computed tomography and magnetic resonance imaging for improved pulmonary nodule detection and lung cancer staging. J Magn Reson Imag 2010, 32(6):1353-1369.
13. Heyer C.M., Mohr P., Lemburg S.P., et al. Image quality and radiation exposure at pulmonary CT angiography with 100- or 120-kVp protocol: prospective randomized study. Radiology 2007, 245:577-583.
14. Goerres G.W., Burger C., Schwitter M.R., et al. PET/CT of the abdomen: optimizing the patient breathing pattern. Eur Radiol 2003, 13(4):734-739.
15. Beyer T., Antoch G., Muller S.P., et al. Acquisition protocol considerations for combined PET/CT Imaging. J Nucl Med 2004, 45:25s-35s.
16. Puderbach M., Hintze C., Ley S., et al. MR imaging of the chest: a practical approach at 1.5T. Eur J Radiol 2007, 64:345-355.
17. Biederer J., Hintze C., Fabel M. MRI of pulmonary nodules: technique and diagnostic value. Cancer Imaging 2008, 8:125-130.
18. Hochhegger B., Marchiori E., Sedlaczek O., et al. MRI in lung cancer: a pictorial essay. Br J Radiol 2011, 84:661-668.
19. Sieren J.C., Ohno Y., Koyama H., et al. Recent technological and application developments in computed tomography and magnetic resonance imaging for improved pulmonary nodule detection and lung cancer staging. J Magn Reson Imaging 2010, 32:1353-1369.
20. MacMahon H., Austin J.H., Gamsu G., et al. Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society. Radiology 2005, 237:395-400.
21. Yankelevitz D.F., Gupta R., Zhao B., et al. Small pulmonary nodules: evaluation with repeat CT-preliminary experience. Radiology 1999, 212:561-566.
22. Yankelevitz D.F., Reeves A.P., Kostis W.J., et al. Small pulmonary nodules: volumetrically determined growth rates based on CT evaluation. Radiology 2000, 217:251-256.
23. Petrou M., Qunit L.E., Nan B., et al. Pulmonary nodule volumetric measurement variability as a function of CT slice thickness and nodule morphology. AJR Am J Roentgenol 2007, 188:306-312.
24. Aberle D.R., Adams A.M., Berg C., et al. Reduced lung-cancer mortality with low-dose Computed Tomographic Screening. N Engl J Med 2011, 365:395-409.
25. Fischer B.M., Mortensen J., Hojgaard L. Positron emission tomography in the diagnosis and staging of lung cancer: a systematic, quantitative review. Lancet Oncol 2001, 2(11):659-666.
26. Gould M.K., Maclean C.C., Kuschner W.G., et al. Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis. JAMA 2001, 285(7):914-924.
27. 18F-FDG PET and CT in the characterization of solitary pulmonary nodules. J Nucl Med 2008, 49:179-185.
28. Detterbeck F.C., Falen S., Rivera M.P., et al. Seeking a home for a PET, part 1: defining the appropriate place for positron emission tomography imaging in the diagnosis of pulmonary nodules or masses. Chest 2004, 125:2294-2299.
29. Downey R.J., Akhurst T., Gonen M., et al. Preoperative F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value predicts survival after lung cancer resection. J Clin Oncol 2004, 22:3255-3260.
30. Gulenchyn KY, Farncombe TH, Maziak DE, et al. Survival of non-small cell lung cancer (NSCLC) patients in a randomized trial as predicted by the FDG-PET standardized uptake value (SUV). 2010 ASCO Annual Meeting abstract. Chicago (IL), June 4-8, 2010.
31. Biederer J., Schoene A., Freitag S., et al. Simulated pulmonary nodules implanted in a dedicated porcine chest phantom: sensitivity of MR imaging for detection. Radiology 2003, 227:475-483.
32. Both M., Schultze J., Reuter M., et al. Fast T1- and T2-weighted pulmonary MR-imaging in patients with bronchial carcinoma. Eur J Radiol 2005, 53:478-488.
33. Schroeder T., Ruehm S.G., Debatin J.F., et al. Detection of pulmonary nodules using a 2D HASTE MR sequence: comparison with MDCT. AJR Am J Roentgenol 2005, 185:979-984.
34. Bruegel M., Gaa J., Woertler K., et al. MRI of the lung: value of different turbo spin-echo, single-shot turbo spin-echo, and 3D gradient-echo pulse sequences for the detection of pulmonary metastases. J Magn Reson Imaging 2007, 25:73-81.
35. Koyama H., Ohno Y., Kono A., et al. Quantitative and qualitative assessment of non-contrast-enhanced pulmonary MR imaging for management of pulmonary nodules in 161 subjects. Eur Radiol 2008, 18:2120-2131.
36. Wu N.Y., Cheng H.C., Ko J.S., et al. Magnetic resonance imaging for lung cancer detection: experience in a population of more than 10,000 healthy individuals. BMC Cancer 2011, 11:242.
37. Regier M., Schwarz D., Henes F.O., et al. Diffusion-weighted MR-imaging for the detection of pulmonary nodules at 1.5 Tesla: intraindividual comparison with multidetector computed tomography. J Med Imaging Radiat Oncol 2011, 55:266-274.
38. Satoh S., Kitazume Y., Ohdama S., et al. Can malignant and benign pulmonary nodules be differentiated with diffusion-weighted MRI?. AJR Am J Roentgenol 2008, 191:464-470.
39. Uto T., Takehara Y., Nakamura Y., et al. Higher sensitivity and specificity for diffusion-weighted imaging of malignant lung lesions without apparent diffusion coefficient quantification. Radiology 2009, 252:247-254.
40. Koyama H., Ohno Y., Aoyama N., et al. Comparison of STIR turbo SE imaging and diffusion-weighted imaging of the lung: capability for detection and subtype classification of pulmonary adenocarcinomas. Eur Radiol 2010, 20:790-800.
41. Glazer H.S., Kaiser L.R., Anderson D.J., et al. Indeterminate mediastinal invasion in bronchogenic carcinoma: CT evaluation. Radiology 1989, 173:37-42.
42. Scott I.R., Muller N.L., Miller R.R., et al. Resectable stage III lung cancer: CT, surgical and pathological correlation. Radiology 1988, 166:75-79.
43. Herman S.J., Winton T.I., Weisbrod G.L., et al. Mediastinal invasion by bronchogenic carcinoma: CT signs. Radiology 1994, 190:841-846.
44. White P.G., Admas H., Crane M.D., et al. Preoperative staging of carcinomas of the bronchus: can computed tomography scanning reliably identify stage III tumours?. Thorax 1994, 49:951-957.
45. Laurent F., Drouillard J., Dorcier F. Bronchogenic carcinoma staging: CT vs MR imaging-assessment with surgery. Eur J Cardiothorac Surg 1988, 2:31-36.
46. Higashino T., Ohno Y., Takenaka D., et al. Thin-section multiplanar reformats from multidetector-row CT data; utility for assessment of regional tumour extent in non-small cell lung cancer. Eur J Radiol 2005, 56:48-55.
47. Wintersperger B.J. Imaging of cardiac and paracardiac masses and pseudotumors. CT of the heart: principles and applications 2005, 171-182. Humana Press, New Jersey, part IV. U.J. Schoepf (Ed.).
48. Halpern B.S., Schiepers C., Weber W.A., et al. Presurgical staging of non-small cell lung cancer: positron emission tomography, integrated positron emission tomography/CT, and software image fusion. Chest 2005, 128:2289-2297.
49. De Wever W., Stroobants S., Coolen J., et al. Integrated PET/CT in the staging of non-small cell lung cancer: technical aspects and clinical integration. Eur Respir J 2009, 33:201-212.
50. Webb W.R., Gatsonis C., Zerhouni E.A., et al. CT and MR imaging in staging non-small cell bronchogenic carcinoma: report of the Radiologic Diagnostic Oncology Group. Radiology 1991, 178:705-713.
51. White C.S. MR evaluation of the pericardium and cardiac malignancies. Magn Reson Imaging Clin N Am 1996, 4:237-251.
52. Seo J.S., Kim Y.J., Choi B.W., et al. Usefulness of magnetic resonance imaging for evaluation of cardiovascular invasion: evaluation of sliding motion between thoracic mass and adjacent structures on cine MR images. J Magn Reson Imaging 2005, 22:234-241.
53. Sakai S., Murayama S., Murakami J., et al. Bronchogenic carcinoma invasion of the chest wall: evaluation with dynamic cine MRI during breathing. J Comput Assist Tomogr 1997, 21:595-600.
54. Ohno Y., Adachi S., Motoyama A., et al. Multiphase ECG-triggered 3D contrast-enhanced MR angiography: utility for evaluation of hilar and mediastinal invasion of bronchogenic carcinoma. J Magn Reson Imaging 2001, 13:215-224.
55. Glazer G.M., Gross B.H., Quint L.E., et al. Normal mediastinal lymph nodes: number and size according to American Thoracic Society mapping. AJR Am J Roentgenol 1985, 144:261-265.
56. Kiyono K., Sone S., Sakai F., et al. The number and size of normal mediastinal lymph nodes: a post mortem study. AJR Am J Roentgenol 1985, 150:771-776.
57. Kerr K.M., Lamb D., Wathen C.G., et al. Pathological assessment of mediastinal lymph nodes in lung cancer: implications for non invasive staging. Thorax 1992, 47:337-341.
58. McCloud T.C., Bourgouin P.M., Greenberg R.W., et al. Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling. Radiology 1992, 182:319-323.
59. Gross B.H., Glazer G.M., Orringer M.B., et al. Bronchogenic carcinoma metastatic to normal sized lymph nodes: frequency and significance. Radiology 1986, 166:71-74.
60. 18FDG-PET-CT?. Eur Radiol 2012, 22:93-103.
61. Ung Y, Walker-Dilks C. Program in evidence-based care. PET recommendation report 9. PET imaging in small cell lung cancer. Available at: Accessed April 22, 2012. https://www.cancercare.on.ca/.
62. Cerfolio R.J., Bryant A.S., Eloubeidi M.A. Routine mediastinoscopy and esophageal ultrasound fine-needle aspiration in patients with non-small cell lung cancer who are clinically N2 negative: a prospective study. Chest 2006, 130(6):1791-1795.
63. Darling G.E., Maziak D.E., Incluet R.I., et al. Positron emission tomography-computed tomography compared with invasive mediastinal staging in non-small cell lung cancer: results of mediastinal staging in the early lung positron emission tomography trial. J Thorac Oncol 2011, 6(8):1367-1372.
64. Shim S.S., Lee K.S., Kim B.T., et al. Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging. Radiology 2005, 236:1011-1019.
65. Yi C.A., Shin K.M., Lee K.S., et al. Non-small cell lung cancer staging: efficacy comparison of integrated PET/CT versus 3.0-T whole-body MR imaging. Radiology 2008, 248:632-642.
66. Ohno Y., Koyama H., Nogami M., et al. STIR turbo SE MR imaging vs. coregistered FDG-PET/CT: quantitative and qualitative assessment of N-stage in non-small-cell lung cancer patients. J Magn Reson Imaging 2007, 26:1071-1080.
67. Ohno Y., Koyama H., Yoshikawa T., et al. N stage disease in patients with non-small cell lung cancer: efficacy of quantitative and qualitative assessment with STIR turbo spin-echo imaging, diffusion-weighted MR imaging, and fluorodeoxyglucose PET/CT. Radiology 2011, 261:605-615.
68. Takenaka D., Ohno Y., Hatabu H., et al. Differentiation of metastatic versus non-metastatic mediastinal lymph nodes in patients with non-small cell lung cancer using respiratory-triggered short inversion time inversion recovery (STIR) turbo spin-echo MR imaging. Eur J Radiol 2002, 44:216-224.
69. Nakayama J., Miyasaka K., Omatsu T., et al. Metastases in mediastinal and hilar lymph nodes in patients with non-small cell lung cancer: quantitative assessment with diffusion-weighted magnetic resonance imaging and apparent diffusion coefficient. J Comput Assist Tomogr 2010, 34:1-8.
70. Spencer H. Pathology of the lung 1985, Pergamon Press, Oxford (United Kingdom), p. 924. 4th edition.
71. Sica G.T., Ji H., Ros P.R. CT and MR imaging of hepatic metastases. AJR Am J Roentgenol 2000, 174:691-698.
72. Bradbury I., Bonnell E., Boynton J., et al. Positron emission tomography (PET) imaging in cancer management 2002, Health Technology Board for Scotland, Glasgow (Scotland), Health Technology Assessment Report No.: 2.
73. The diagnosis and treatment of lung cancer (CG121). In: Clinical Guidelines April 2011. Available at: Accessed April 25, 2012. http://www.nice.org.uk/nicemedia/pdf/CG024niceguideline.pdf.
74. 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) versus conventional imaging (CI) in staging potentially resectable non-small cell lung cancer (NSCLC). J Clin Oncol 2008, 26(Suppl):739s. [abstract: 7502].
75. Ohno Y., Koyama H., Dinkel J., et al. Lung cancer. MRI of the lung 2009, 179-216. Springer. H.-U. Kauczor (Ed.).
76. Schmidt G.P., Baur-Melnyk A., Herzog P., et al. High-resolution whole-body magnetic resonance image tumor staging with the use of parallel imaging versus dual-modality positron emission tomography-computed tomography: experience on a 32-channel system. Invest Radiol 2005, 40:743-753.
77. Ohno Y., Koyama H., Onishi Y., et al. Non-small cell lung cancer: whole-body MR examination for M-stage assessment-utility for whole-body diffusion-weighted imaging compared with integrated FDG PET/CT. Radiology 2008, 248:643-654.
78. Fischer B., Lassen U., Mortensen J., et al. Preoperative staging of lung cancer with combined PET-CT. N Engl J Med 2009, 361:32-39.
79. Maziak D.E., Darling G.E., Inculet R.I., et al. Positron emission tomography in staging early lung cancer: a randomized trial. Ann Intern Med 2009, 151:221-228. W-48.
80. Detterbeck F.C., Jantz M.A., Wallace M., et al. Invasive mediastinal staging of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007, 132(Suppl 3):202S-220S.
81. *: ACCP evidenced-based clinical practice guidelines (2nd edition). Chest 2007, 132:178S-201S.